DE2601783A1 - Dispirodecanderivate, verfahren zu ihrer herstellung und sie enthaltende arzneimittel - Google Patents

Dispirodecanderivate, verfahren zu ihrer herstellung und sie enthaltende arzneimittel

Info

Publication number
DE2601783A1
DE2601783A1 DE19762601783 DE2601783A DE2601783A1 DE 2601783 A1 DE2601783 A1 DE 2601783A1 DE 19762601783 DE19762601783 DE 19762601783 DE 2601783 A DE2601783 A DE 2601783A DE 2601783 A1 DE2601783 A1 DE 2601783A1
Authority
DE
Germany
Prior art keywords
general formula
molecular weight
low molecular
alkyl group
aza
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE19762601783
Other languages
German (de)
English (en)
Inventor
Jean-Claude Dr Med Poignant
Georges Remond
Michel Vincent
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Science Union et Cie
Original Assignee
Science Union et Cie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Science Union et Cie filed Critical Science Union et Cie
Publication of DE2601783A1 publication Critical patent/DE2601783A1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/04—1,3-Dioxanes; Hydrogenated 1,3-dioxanes
    • C07D319/08—1,3-Dioxanes; Hydrogenated 1,3-dioxanes condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/673—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by change of size of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/54—Spiro-condensed
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/72—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 spiro-condensed with carbocyclic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Neurology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
DE19762601783 1975-01-24 1976-01-20 Dispirodecanderivate, verfahren zu ihrer herstellung und sie enthaltende arzneimittel Withdrawn DE2601783A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB325175A GB1478224A (en) 1975-01-24 1975-01-24 Dispiroalkanes processes for their preparation and pharma ceutical compositions containing them

Publications (1)

Publication Number Publication Date
DE2601783A1 true DE2601783A1 (de) 1976-07-29

Family

ID=9754813

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19762601783 Withdrawn DE2601783A1 (de) 1975-01-24 1976-01-20 Dispirodecanderivate, verfahren zu ihrer herstellung und sie enthaltende arzneimittel

Country Status (9)

Country Link
US (1) US4086355A (pt-PT)
JP (1) JPS5627518B2 (pt-PT)
BE (1) BE837877A (pt-PT)
CA (1) CA1088074A (pt-PT)
DE (1) DE2601783A1 (pt-PT)
ES (1) ES444600A1 (pt-PT)
FR (1) FR2298327A1 (pt-PT)
GB (1) GB1478224A (pt-PT)
NL (1) NL7600631A (pt-PT)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH27359A (en) * 1989-08-25 1993-06-21 Warner Lambert Co Process for cyclic amino acid anticonvulsant compounds

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3238217A (en) * 1961-09-07 1966-03-01 Geschickter Fund Med Res Azaspiranes
US3534054A (en) * 1968-02-05 1970-10-13 Lilly Co Eli 3,6-dioxo-2-aza-9,11,14-trioxadispiro (4.1.5.3) pentadecane
US3669986A (en) * 1970-02-27 1972-06-13 Lilly Co Eli Substituted dispiropentadecanes

Also Published As

Publication number Publication date
FR2298327B1 (pt-PT) 1979-09-21
US4086355A (en) 1978-04-25
ES444600A1 (es) 1977-05-01
NL7600631A (nl) 1976-07-27
FR2298327A1 (fr) 1976-08-20
JPS51105066A (pt-PT) 1976-09-17
CA1088074A (fr) 1980-10-21
GB1478224A (en) 1977-06-29
JPS5627518B2 (pt-PT) 1981-06-25
BE837877A (fr) 1976-07-23

Similar Documents

Publication Publication Date Title
DD270529A5 (de) Verfahren zur herstellung von naphthalinderivaten
DE2733868A1 (de) Neue 1,2,4,5-tetrahydro-3h-2-benzazepin-3-one, verfahren zu ihrer herstellung und diese enthaltende arzneimittel
DE69823803T2 (de) Benzofurazan derivate zur modelierung der ampa-rezeptor-aktivität
CH630604A5 (de) Verfahren zur herstellung von neuen acetylenderivaten von aminosaeuren.
DE2065635B2 (de) 10-Dioxo-11 -methyldibenzothiazepinderivate, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Zubereitungen
AT376977B (de) Verfahren zur herstellung von neuen 5-substituierten oxazolidin-2,4-dionen und ihren salzen
DE2923368A1 (de) Neue 5-fluor-( beta -uridin oder 2'-desoxy- beta -uridin)-derivate, verfahren zur herstellung derselben und carcinostatische mittel mit einem gehalt derselben
DE68917357T2 (de) Derivate der Coffeinsäure und pharmazeutische Zusammensetzungen, die sie enthalten.
DE69103968T2 (de) 2-(Aminoalkyl)-5-(arylalkyl)1,3-dioxanderivate, ihre Herstellung und ihre Anwendung in der Therapeutik.
EP0767174A1 (de) Neue Aminoalkanphosphinsäuren und ihre Salze
EP0771813B1 (de) Alkylxanthinphosphonate und Alkylxanthinphosphinoxide und deren Verwendung als Arzneimittel
DE3739882A1 (de) Substituierte hydroxylamine
DE3854981T2 (de) 1-Pyrrolidinacetamid-Derivate und ihre Verwendung
DE1493912A1 (de) Naphthylessigsaeuren und Verfahren zu deren Herstellung
DE2601783A1 (de) Dispirodecanderivate, verfahren zu ihrer herstellung und sie enthaltende arzneimittel
EP0002672A2 (de) Substituierte Pyrrolidine, Verfahren zu ihrer Herstellung und sie enthaltende Arzneimittel
DE3925477A1 (de) Neue verbindungen der 3-isoxazolidinon-, 2h-1,2-oxazin-3-(4h)-on- und 3-isoxazepinon-serien
DD300542A5 (de) Chemische verbindungen
EP0420806B1 (de) Phosphonsäure, Verfahren zur Herstellung und Verwendung als Arzneimittelwirkstoff
EP0002836B1 (de) Acylhydrocarbylaminoalkansäuren, ihre Herstellung und Verwendung sowie sie enthaltende Arzneimittel
DE2914805A1 (de) Tetrahydroalstoninderivate, verfahren zu ihrer herstellung und sie enthaltende arzneimittel
DE2917890C2 (pt-PT)
DE2656750C2 (de) In 5-Stellung substituierte 2-Indancarbonsäuren, Verfahren zu deren LIPHA-Herstellung und sie enthaltende Arzneimittel
DE3245950A1 (de) Verfahren zur herstellung substituierter pyridine
CH505850A (de) Verfahren zur Herstellung von neuen Benzoxazepinonen

Legal Events

Date Code Title Description
8139 Disposal/non-payment of the annual fee